CSGALNACT2 anticorps (AA 33-270) (FITC)

N° du produit ABIN7147642

Cet anticorps anti-CSGALNACT2 est un anticorps Lapin Polyclonal détectant CSGALNACT2 dans . Adapté pour Humain.

Aperçu rapide pour CSGALNACT2 anticorps (AA 33-270) (FITC) (ABIN7147642)

Antigène: CSGALNACT2 (Chondroitin Sulfate N-Acetylgalactosaminyltransferase 2 (CSGALNACT2))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CSGALNACT2 est conjugé à/à la FITC

Application: Veuillez nous consulter SVP

Détail du produit anti-CSGALNACT2 anticorps (FITC)

Épitope: AA 33-270

Fonction: CSGALNACT2 Antibody, FITC conjugated

Purification: Protein G purified

Pureté: >95 %

Immunogène: Recombinant Human Chondroitin sulfate N-acetylgalactosaminyltransferase 2 protein (33-270AA)

Isotype: IgG

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur CSGALNACT2

Antigène: CSGALNACT2 (Chondroitin Sulfate N-Acetylgalactosaminyltransferase 2 (CSGALNACT2))

Autre désignation: CSGALNACT2

Sujet:

Background: Transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of glucuronic acid (GlcUA). Required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains.

Aliases: 4-N-acetylgalactosaminyltransferase 2 antibody, Beta4GalNAcT-2 antibody, CGAT2_HUMAN antibody, CHGN2 antibody, Chondroitin beta-1 antibody, Chondroitin sulfate N-acetylgalactosaminyltransferase 2 antibody, Csgalnact2 antibody, DKFZp686H13226 antibody, FLJ43310 antibody, GALNACT 2 antibody, GalNAcT-2 antibody, GALNACT2 antibody, MGC40204 antibody, PRO0082 antibody

UniProt: Q8N6G5

Pathways: Glycosaminoglycan Metabolic Process